| CAS NO: | 1416334-69-4 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 生物活性 | GSK-A1 is a selectivetype III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα)inhibitor with apIC50of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC50of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research[1]. | |||||||||
| IC50& Target[1] |
| |||||||||
| 分子量 | 574.63 | |||||||||
| 性状 | Solid | |||||||||
| Formula | C29H27FN6O4S | |||||||||
| CAS 号 | 1416334-69-4 | |||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | |||||||||
| 储存方式 |
|
m.cnreagent.com